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Within the framework of epidemiological surveillance by molecular typing tools conducted
in the NRL on multi-resistant strains, the application of spoligotyping on a group of 390
strains consisting of 389 DR-MTB strains and 1 susceptible strain isolated from patients
made it possible to detect the presence of 15 strains belonging to the Beijing genotype.
All 15 strains were genotyped by MTBDRplus. Among the 15 strains, 11 were typed by RFLP
and 9 by MIRU-VNTR.
After analysis of the profiles obtained by the software MIRU-VNTRplus, two spoligotypes
(st No. 1 and st No. 265) and four RFLP profiles and a complete identity profile by MIRU-
VNTR, information collected on patients allowed the research team to detect a family tie
among patients of three different families, as well as one nosocomial TB transmission.
The percentage of Beijing strains found among the patients in this study was 3.8%; this
figure does not reflect the reality because it was calculated from an essay on MDR-TB.
To get an idea of the prevalence of Beijing TB strains in this country, a more extensive
study is currently being considered.
 2012 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
The distribution of multidrug-resistant tuberculosis (TB) in
general is unknown, because the majority of countries are
not equippedwith diagnostic laboratories and only a minority
of laboratories are controlled by the supranational laborato-
ries. The dissemination of strains, especially multidrug-resis-
tant strains, is a real obstacle that compromises both the
effectiveness of treatment and the efforts of the programs
against TB.
Several epidemics associated with multidrug-resistant
strains have been described worldwide, but the most impor-
tant are those related to the Beijing strains. The Beijing geno-
type is widespread, especially in Asian countries, where it-African Society for Myco
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(M. Ifticene), fatmazohrepresents more than 80% of isolated strains and more than
40% in other countries [1–6].
The power of mutation in the genomic regions involved in
the resistance, the rapid evolution of resistance, the low im-
mune response related to their adaptation to the host, com-
pared with other genotypes, gives these strains a
particularly virulent character [7]. Therefore, many studies
have been conducted towards the identification of factors
that promote their dissemination and mechanisms that allow
them to adapt to the host and to its defense mechanisms [8].
Since the introduction of a molecular typing tool in the
laboratory used by the researchers, the existence of 15 Beijing
genotype strains have been identified in a batch of 390 strains
of MTB isolated between 1997 and 2011.bacteriology. All rights reserved.
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Materials
Within the framework of an epidemiological survey on multi-
drug-resistant tuberculosis (MDR-TB), 389 MDR-TB strains of
tuberculosis were studied by spoligotyping. This technique al-
lowed the researchers to identify the existence of 14 Beijing
genotype strains. During the course of the research, a strain
of MTB genotype Beijing was isolated from a Chinese expatri-
ate in Algeria in a professional framework. This latter strain
was susceptible to TB drugs unlike 14 strains isolated in Alge-
rian patients.
Geo-demographic information of patients with Beijing
genotype strains such as age at diagnosis, sex, geographical
origin or the setting of diagnosis, date of diagnosis, treatment
history and outcome of treatment were obtained from the pa-
tients’ files and the laboratory register, as well as some of the
information provided by the treating physician. These data
are shown in Table 1.Methods
Determination of the drug susceptibility
A microscopic examination well as a culture on solid med-
ium was performed on the samples. The study of strain sus-
ceptibility to anti-TB drugs was performed by two methods:
the proportion method on solid media (Isoniazid, Rifampi-
cin, Ethambutol, Streptomycin, Kanamycin and Ofloxacin)
and the molecular biology method as MTBDRplus of HAIN
[9,10].Genotyping of strains
The 15 strains were typed by spoligotyping [11,12]. The RFLP
technique [13,14] was performed on 11 strains and the
MIRU-VNTR technique [15] has been applied on 9 strains ow-
ing to lack of culture material.Table 1 – Geo-demographic data of patients.
Patient
No.
Age Sex Origin and date
of diagnostic
Treatment history Patient
P1 21 F Blida, 2000 UT Cured
P2 39 M Blida, 1997 UT Deceas
P3 24 F Blida, 1998 UT Deceas
P4 28 F Blida, 1999 UT Deceas
P5 42 M Blida, 2000 UT Deceas
P6 29 M Blida, 2002 T Loss o
P7 22 F Algiers, 2002 UT Cured
P8 24 M Algiers, 2004 UT Deceas
P9 19 M China, 2002 UT Expatr
P10 24 M Dellys, 2004 UT Loss o
P11 58 M Miliana, 2002 T Deceas
P12 45 M Dellys, 2004 T Deceas
P13 27 M Dellys, 2007 UT Loss o
P14 54 M Algiers, 2003 UT Loss o
P15 35 M Dellys, 2001 T Deceas
H: Isoniazid, S: Streptomycin, R: Rifampicin, E: Ethambutol, M: male, F: fResults
Geo-demographic characteristics of patients
Among the 390 strains which were studied by spoligotyping,
15 Beijing genotype strains have been identified. All patients
presented with pulmonary TB, including 4 females and 11
males. The age range was between 19 and 58 years.
Of the 15 patients, 2 were cured under treatment (P1,P7), 1
of the 2 in combination with surgical treatment (P1); 4 pa-
tients (P6,P10,P13,P14) lost their sight; and the follow-up of
the disease was fatal after an average of 2 years for 8 patients
(P2,P3,P4,P5,P8,P11,P12,P15) – a 53% death rate.
Regarding the origin of the patients, all patients harboring
the Beijing strain were diagnosed in the center region of Alge-
ria covering an area of approximately 200 km; 4 (P10, P12, P13
and P15) are from Dellys, a region located in the province of
Tizi Ouzou about 90 km east of Algiers. One patient (P11) is
from Miliana, located 60 km south of Algiers. Six patients
(P1, P2, P3, P4, P5 and P6) are from Blida, 40 kmwest of Algiers.
Three patients are from Algiers (P7, P8 and P14). The 15th pa-
tient (P9) is from China, arrived in Algeria in a professional
setting and whose disease was diagnosed in a TB center of
Algiers.
Links between the 15 patients
A family tie was found between 3 patients from Blida: P1, P2
and P3. Four other cases were identified among members of
two families; one family in Algiers (P7,P8), and the second
one in Dellys (P12,P13). A case of nosocomial TB infection
(P4) has been identified. It concerns the nurse of the care unit
attended by P2.
Drug susceptibility testing
The drug susceptibility testing performed on the 15 strains
showed that those isolated in the Algerian patient are resis-
tant to at least RH (study material of investigation MDR-TB).outcome and relationship with other patients of the group
after lobectomy (niece of P2 and P3)
ed (uncle of P1)
ed
ed (nurse in the healthcare center of P2)
ed
f sight since 2003
(sister of P8)
ed on post surgical in 2012 (operation on the affected lung)
iate, returned to China immediately after diagnosis
f sight since 2005
ed
ed (brother of P13)
f sight since 2008
f sight since 2004
ed
emale, T: treated, UT: untreated.















P1 HSRE Dwt7, mut2a (rpoB) P9 Susceptible Susceptible
Dwt, mut1 (KatG)
Dwt1, mut1 (inhA)
P2 HSRE Dwt7, mut2a (rpoB) P10 HSR DWt8, mut3 (rpoB)
Dwt, mut1 (KatG) DWt, mut1 (KatG)
Dwt1, mut1 (inhA) DWt1, mut1
P3 HSRE wt7, mut2a (rpoB) P11 HSR ND
Dwt, mut1 (KatG)
Dwt1, mut1 (inhA)
P4 HSRE Dwt7, mut2a (rpoB) P12 HSR DWt8, mut3 (rpoB)
Dwt, mut1 (KatG) DWt, mut1 (KatG)
Dwt1, mut1 (inhA) DWt1, mut1 (inhA)
P5 HSRE wt7, mut2a (rpoB) P13 HSR WT8, mut3 (rpoB)
Dwt, mut1 (KatG) DWt, mut1 (KatG)
Dwt1, mut1 (inhA) DWt1, mut1 (inhA)
P6 HSRE Dwt7, mut2a (rpoB) P14 HSR Wt8, mut3 (rpoB)
Dwt, mut1 (KatG) DWt, mut1 (KatG)
Dwt1, mut1 (inhA DWt1, mut1 (inhA)
P7 HSRE Dwt7, mut2a (rpoB) P15 HSR ND
Dwt, mut1 (KatG)
Dwt1, mut1 (inhA)
P8 HSRE Dwt7, mut2a (rpoB)
Dwt, mut1 (KatG)
Dwt1, mut1 (inhA)
D: disappearance of the wildtype probe; mut: mutation probe; ND: not done.
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is sensitive to TB. Apart from two strains (P11,P15) for which
the test MTBDRplus could not be performed, the results of
susceptibility testing by the proportion method and by the
method of MTBDRplus HAIN are totally concordant and are
shown in Table 2.
By the MTBDplus method, two types of mutations have
been found in the rpoB gene: the first corresponds to
DWt7, mut2a, identified in strains of patients 1, 2, 3, 4, 5,
6, 7, 8 (P1, P2, P3 on the one hand and P7, P8 on the other
hand present family tie). The second mutation DWt8, mut3
was identified on strains of patients 10, 12, 13, 14, among
them P12 and P13 have a family tie. The mutations found
in the katG gene and inhA gene promoter were identical
for the 15 strains.Molecular typing
Spoligotyping
The profiles of the 390 strains typed by spoligotyping after
their comparison to the database SPOLD4 [16] confirmed that
15 strains belong to the Beijing genotype [17].
In this study, of the 15 Beijing strains, 2 spoligotypes were
found. The ST1 consists of a cluster of 11 strains and ST 265
consists of a 4-strain cluster; the latter cluster is character-
ized by the lack of the 37th spacer in addition to the first 34.RFLP typing
Of the 15 selected Beijing strains, 11 were typed by RFLP. Four
different profiles were identified. The number of copies per
profile varies between 15 and 16 features attributed to the Bei-
jing genotype strains (Fig. 1). The first 6 profiles (1, 2, 3, 4, 5
and 6 in Fig. 1) are identical and correspond to the group of
patients of Blida; the 7th and 8th are the same group of Al-
giers patients (brother and sister), the 12th and 13th are iden-
tical and correspond to the group of Dellys (two brothers), and
the last profile (9) belongs to the Chinese patient (single pro-
file). Strains of 4 patients (10, 11, 14 and 15) have not been
analyzed by RFLP owing to lack of material.
MIRU-VNTR typing
Among the 15 strains, 9 were typed by 15 MIRU-VNTR (strains
of patients 1, 4, 6, 7, 9, 12, 13, 14 and 15). Results of this tech-
nique were analyzed by the software MIRU-VNTRplus. They
showed that 9 strains have the same number of repetitions
for the same MIRU VNTR. The results of the susceptibility
testing and the three genotyping techniques are shown in
Fig. 1.
Discussion
An epidemiological surveillance essay on the MDR-TB strains
by molecular typing tools performed in the researcher’s labo-
ratory (spoligotyping, RFLP and MIRU-VNTR) revealed the ge-
Fig. 1 – Results of the susceptibility testing and three genotyping techniques, analyzed by the software MIRU-VNTRplus.
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most commonly encountered clades (LAM,H,S), the Beijing
genotype was found among the 15 strains isolated from pul-
monary TB patients, including 14 Algerians carrying MDR
strains and 1 Chinese patient with a drug susceptible strain.
These strains were isolated from patients distributed over a
geographic area covering approximately 4000 km2: Blida, Al-
giers, Tizi Ouzou and Miliana.
The analysis of the profiles obtained by spoligotyping has
regained two clusters, one of which bears the spoligotype 1
and the other, the spoligotype 265. Typing by RFLP objectified
four different profiles. However, the MIRU-VNTR typing
showed an identity of profiles between 9 strains typed by
MIRU-VNTR 15; by this method, identical results were cited
in a study conducted in Benin [18].
The detection of the same genomic profile of strains iso-
lated from patients belonging to the same family and that live
in the same geographic area was a clue as to the household as
well as the community transmission of tubercle bacilli.
An epidemiological investigation in the field confirmed the
existence of a family tie between members of three different
families: P1, P2, P3 in Blida, among them, two members are
dead and one is cured after surgical treatment in combination
with medical treatment. As for patients P7 and P8 from Al-
giers, one of them was cured after 2 years of treatment and
the other died after surgery on the lung. Among members
of the family of Dellys, P12 and P13, one of them died after
2 years of treatment. A case of nosocomial TB was diagnosed
in a nurse at the TB health center (P4) where her work in-
volved the treatment of TB patients (Table 1).
In a batch of 390 strains analyzed, a Chinese strain suscep-
tible to anti-TB drugs was typed. It turned out that its molec-
ular profile obtained by RFLP is different from those isolated
in Algerian patients, confirming the recent importation of this
strain in Algeria.
The starting point of this epidemic remains undetermined.
The first case diagnosed to be the bearer of the Beijing strain
was in 1997 as a result of the introduction of the genotyping
methods in the laboratory and their application on multi-
drug-resistant strains of Mycobacterium tuberculosis isolated
in pulmonary TB patients.
However, the discovery of strains of the Beijing profile does
not surprise the researchers because Algeria has received,
particularly during the 1970s, many foreign workers of Asian
origin (Chinese and Vietnamese) in the framework of cooper-
ation in the field of health. These were mainly installed in the
central region of Algeria, and exercised in the public sector.The percentage of Beijing strains found in Algeria was 3.8%
(15/390 or 14/389 if the recent Chinese patient is excluded).
This percentage is overestimated because it was calculated
on the Beijing strains isolated from a batch of 389 MDR strains
selected as part of a specific study conducted on MDR-TB
strains.
A significant bias is up and in any case the percentage re-
ported may not represent the prevalence of Beijing family
strains among strains of MTB circulating in the country. It
cannot, in this case, be compared with rates reported in mul-
tiple studies conducted worldwide on the Beijing genotype of
M. tuberculosis.
Therefore, an important research is under way to assess
the prevalence of the Beijing family strains on a representa-
tive sample of strains isolated during a long observation per-
iod (1990–2010), without prejudice to the susceptibility or the
resistance to anti-tuberculosis drugs.
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